ABL Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	10,665,612	11,025,033	1,443,630	1,178,156	1,099,129	1,041,424
Market Cap Growth	464.97%	663.70%	22.53%	7.19%	5.54%	-
Enterprise Value	10,607,972	10,941,258	1,335,337	1,126,398	1,038,936	-
Last Close Price	190500.00	200000.00	29900.00	24600.00	23000.00	22100.00
PE Ratio	-	-	-	-	342.55	-
PS Ratio	134.41	138.94	43.22	17.97	16.33	195.31
PB Ratio	68.07	70.36	8.63	15.90	15.81	18.61
P/TBV Ratio	70.24	72.60	8.91	16.47	16.43	19.50
P/FCF Ratio	-	-	-	-	15.69	-
P/OCF Ratio	-	-	-	-	15.24	-
EV/Sales Ratio	133.69	137.89	39.98	17.18	15.44	-
EV/EBITDA Ratio	-	-	-	-	321.37	-
EV/EBIT Ratio	-	-	-	-	1144.20	-
EV/FCF Ratio	-173.00	-	-	-	14.83	-
Debt / Equity Ratio	0.35	0.35	0.26	0.59	0.60	0.01
Debt / EBITDA Ratio	-	-	-	-	12.94	-
Debt / FCF Ratio	-	-	-	-	0.60	-
Net Debt / Equity Ratio	-0.38	-0.38	-0.58	-0.37	-0.52	-0.77
Net Debt / EBITDA Ratio	1.61	1.61	1.72	996.51	-11.28	0.88
Net Debt / FCF Ratio	0.97	0.97	1.25	0.80	-0.52	1.03
Asset Turnover	0.31	0.31	0.17	0.38	0.54	-
Quick Ratio	1.41	1.41	2.24	1.71	1.09	5.01
Current Ratio	1.43	1.43	2.28	1.81	1.12	5.20
Return on Equity (ROE)	-23.38%	-23.38%	-46.01%	-3.69%	5.12%	-
Return on Assets (ROA)	-9.84%	-9.84%	-18.93%	-0.95%	0.45%	-
Return on Capital Employed (ROCE)	-25.70%	-25.70%	-35.20%	-2.20%	0.80%	-90.30%
Earnings Yield	-0.35%	-0.34%	-3.85%	-0.22%	0.29%	-4.18%
FCF Yield	-0.57%	-0.56%	-5.43%	-2.90%	6.38%	-4.02%
Buyback Yield / Dilution	-7.23%	-7.23%	-0.40%	-0.58%	-1.27%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.